101. Essential Role of Growth Hormone and IGF-1 in Therapeutic Effect of Ghrelin in the Course of Acetic Acid-Induced Colitis.
- Author
-
Ceranowicz P, Warzecha Z, Cieszkowski J, Ceranowicz D, Kuśnierz-Cabala B, Bonior J, Jaworek J, Ambroży T, Gil K, Olszanecki R, Pihut M, and Dembiński A
- Subjects
- Acetic Acid, Animals, Colitis blood, Colitis chemically induced, Colitis pathology, Colon drug effects, Colon pathology, Ghrelin pharmacology, Growth Hormone analysis, Insulin-Like Growth Factor I analysis, Intestinal Mucosa drug effects, Intestinal Mucosa pathology, Male, Rats, Wistar, Colitis drug therapy, Ghrelin therapeutic use, Growth Hormone metabolism, Insulin-Like Growth Factor I metabolism
- Abstract
Previous studies have shown that ghrelin exhibits a protective and therapeutic effect in the gut. The aim of the present study was to examine whether administration of ghrelin affects the course of acetic acid-induced colitis and to determine what is the role of growth hormone (GH) and insulin-like growth factor-1 (IGF-1) in this effect. In sham-operated or hypophysectomized male Wistar rats, colitis was induced by enema with 1 mL of 3% solution of acetic acid. Saline or ghrelin (given at the dose of 8 nmol/kg/dose) was administered intraperitoneally twice a day. Seven days after colitis induction, rats were anesthetized and the severity of the colitis was assessed. Treatment with ghrelin reduced the area of colonic mucosa damage in pituitary-intact rat. This effect was associated with increase in serum levels of GH and IGF-1. Moreover, administration of ghrelin improved blood flow in colonic mucosa and mucosal cell proliferation, as well as reduced mucosal concentration of proinflammatory interleukin-1β (IL-1β) and activity of myeloperoxidase. Hypophysectomy reduced serum levels of GH and IGF-1 and increased the area of colonic damage in rats with colitis. These effects were associated with additional reduction in mucosal blood follow and DNA synthesis when compared to pituitary-intact rats. Mucosal concentration of IL-1β and mucosal activity of myeloperoxidase were maximally increased. Moreover, in hypophysectomized rats, administration of ghrelin failed to affect serum levels of GH or IGF-1, as well as the healing rate of colitis, mucosal cell proliferation, and mucosal concentration of IL-1β, or activity of myeloperoxidase. We conclude that administration of ghrelin accelerates the healing of the acetic acid-induced colitis. Therapeutic effect of ghrelin in experimental colitis is mainly mediated by the release of endogenous growth hormone and IGF-1., Competing Interests: The authors declare no conflict of interest.
- Published
- 2017
- Full Text
- View/download PDF